-
1 . Academic Journal
P-266: Favorable outcomes of 3-weekly daratumumab-based regimens in relapsed/refractory multiple myeloma: impact of MRD, rapid doubling time, LDH, triplets and quadruplets
- 저자
- by Ngai, Cheong; Tang, Hoi Ki Karen; Fung, Chi Yeung; Hwang, Yu Yan; Wong, Kai Chung Vincent, et al.
- 소스
- In Clinical Lymphoma, Myeloma and Leukemia August 2022 22 Supplement:S184-S184